Related Experiment Video
Updated: Jan 8, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Hospital burden of Respiratory Syncytial Virus in children in Spain (2016-2022): A retrospective study
Ruth Gil-Prieto1, Rafael García-Carretero1, Valentín Hernandez-Barrera1
1Medical Specialities and Public Health Department, Area of Preventive Medicine and Public Health, Rey Juan Carlos University, Madrid, Spain.
Insights
Respiratory Syncytial Virus (RSV) causes significant hospitalizations in Spanish children, especially infants under one year old. Prevention strategies are crucial to reduce this pediatric burden and associated healthcare costs.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Respiratory Syncytial Virus (RSV) is a primary cause of severe respiratory infections in young children.
- Infants and children under two years old are particularly vulnerable to RSV complications.
Purpose of the Study:
- To quantify the population-based burden of RSV-related hospitalizations in Spain among individuals under 19 years from 2016 to 2022.
- To analyze hospitalization rates, mortality, case fatality, and healthcare costs associated with RSV in different pediatric age groups.
Main Methods:
- Retrospective analysis of national hospital discharge data in Spain (2016-2022).
- Evaluation of hospitalization rates, mortality, case fatality, and costs stratified by age and year.
- Analysis of the impact of comorbidities on case fatality rates.
Main Results:
- Over 166,000 RSV hospitalizations occurred, predominantly in children under five (94.60%) and infants under one (66.22%).
- Infants under one year had the highest hospitalization rate (4,367.87 per 100,000), peaking in 2022. Highest mortality was also in this group.
- Comorbidities significantly increased case fatality in children under five (0.76% vs. 0.02%). RSV burden decreased during COVID-19 pandemic years.
Conclusions:
- RSV represents a substantial public health burden on the pediatric population in Spain, with infants being the most affected.
- The study highlights the significant economic impact, exceeding €497 million in total costs.
- Effective preventive measures, including immunization and early interventions, are essential to mitigate RSV's impact on children.
Abstract:
Respiratory Syncytial Virus (RSV) is a leading cause of acute lower respiratory tract infections, particularly in children under two years of age. This study aimed to estimate the population-based burden of RSV-related hospitalizations in individuals under 19 y in Spain from 2016 to 2022. A retrospective analysis was conducted using national hospital discharge data. Hospitalization rates, mortality, case fatality, and associated healthcare costs were analyzed by age group and year. A total of 166,046 RSV-related hospitalizations were recorded (57.36% male), with 94.60% in children under 5 y and 66.22% in infants under 1 y. The highest mean hospitalization rate was observed in infants <1 y (4,367.87 per 100,000), increasing to 5882.06 in 2022. Mortality was highest in infants <1 y (2.9 per 100,000), while the highest case fatality rates occurred in the 10-14 (0.89%) and 15-19 (0.92%) age groups. Children <5 y with comorbidities had significantly higher case fatality (0.76%) compared to those without (0.02%; OR=31.76). Hospitalization and mortality rates were lowest during the COVID-19 pandemic years. The mean cost per hospitalization was €3,169.63 for children <5 y and €3,276.50 for infants <1 y. The total cost exceeded €497 million, with €360 million attributed to infants <1 y. RSV imposes a substantial burden on the pediatric population in Spain, particularly among infants. These findings underscore the need for effective preventive strategies, including immunization and early intervention.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
Respiratory Volumes and Capacities

